Anticoagulation in AF with Cirrhosis, Trends in Anticoagulation for Acute PE, Beta Blockers for Acute MI with Normal EF, Finerenone for HFpEF, Continuous vs Intermittent Infusion for Antibiotics, Cefepime vs Piperacillin-Tazobactam for Sepsis

Last Week in Medicine

It's been a long time, but we are back!
Apologies on the audio quality from Dr. Jenkins. Apparently he was recording from inside a cardboard box.
Today we talk about important, practice changing studies in internal medicine from the last several months. What's the best anticoagulant in patients with cirrhosis and atrial fibrillation? Why do doctors use so much unfractionated heparin for acute PE? Should we still be using beta blockers in patients with acute MI? Does finerenone improve outcomes in HFpEF? Is continuous infusion of antibiotics better than intermittent? And will the cefepime vs piperacillin-tazobactam battle ever end?
Apixaban, Rivaroxaban and Warfarin in Cirrhosis for AF
Anticoagulation Trends for Acute PE
Beta Blockers for Acute MI with Normal EF
Finerenone for HFpEF FINEARTS-HF
Continuous vs Intermittent Infusion of Beta-Lactams BLING III
Prolonged vs Intermittent Infusions of Beta-Lactams Meta-analysis
Piperacillin-Tazobactam vs Cefepime for Sepsis
Recurrent SBP in Patients on Secondary Prophylaxis